Absolute dosimetry for MR-Linacs
Should cancer incidence rates rise as predicted, Europe’s health services will face escalating demands for investment in advanced therapies assured as safe, personalised, and cost-effective.
In 2020, 2.7 million people in the European Union received a cancer diagnosis. About half underwent radiotherapy, including during diagno...
read more